Acadia Pharmaceuticals Inc.
About
21.10USD-0.22 -1.03%
Closed • Updated at 09:13 GMT+00:00Market Cap$3.61B
P/E Ratio9.61
Volume1.38M
Beta1.09
RSI44.34
Gross Margin91.47%
Acadia Pharmaceuticals Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 6 2026
Acadia Pharmaceuticals Reports First Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance
Apr 30 2026
Acadia Pharmaceuticals Announces Planned Year-End Retirement of Elizabeth H.Z. Thompson, Ph.D., Head of Research and Development, Following a Distinguished Career
Apr 17 2026
Acadia Pharmaceuticals to Present Data at the 2026 American Academy of Neurology (AAN) Annual Meeting
Apr 15 2026
Acadia Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 6, 2026
Apr 7 2026
Acadia Pharmaceuticals Announces DAYBUE® STIX (trofinetide) is Now Broadly Available in the United States for the Treatment of Rett Syndrome
Recent Videos
Your Daily Dose of Dopamine with Holly Valdiviez of Acadia Pharmaceuticals
May 23, 2026
$100M+ Sales & Is Neuren (NEU) Heading for a Record Year? Q1 2026 Update
May 08, 2026
📈ACADIA Pharmaceuticals: The Profitable Ascent of a CNS Powerhouse
Apr 12, 2026
Targeting Psychosis in Alzheimer’s Disease
Apr 01, 2026
Community Chat
Ask AI
Try asking